No photo of Nagaraj Nagathihalli

View Scopus Profile

Nagaraj Nagathihalli

Research Assistant Professor

  • 1380 Citations
20012019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nagaraj Nagathihalli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Targeting cytokine mediated CREB activation in pancreatic cancer

Nagathihalli, N.

National Institutes of Health

7/5/16 → 6/30/18

Project: Research project

    • Research Output

    Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue

    McPherson, L. A., Troccoli, C. I., Ji, D., Bowles, A. E., Gardiner, M. L., Mohsen, M. G., Nagathihalli, N. S., Nguyen, D. M., Robbins, D. J., Merchant, N. B., Kool, E. T., Rai, P. & Ford, J. M., Nov 2019, In : DNA Repair. 83, 102644.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    New mechanistic insights into modifiable risk factors that promote pancreatic cancer

    Srinivasan, S., Dosch, A. R. & Nagathihalli, N. S., Mar 29 2019, In : Oncotarget. 10, 25, p. 2417-2418 2 p.

    Research output: Contribution to journal › Editorial

    Open Access

    Src kinase inhibition restores E-cadherin expression in Dasatinib-sensitive pancreatic cancer cells

    Dosch, A. R., Dai, X., Gaidarski, A. A., Shi, C., Castellanos, J. A., VanSaun, M. N., Merchant, N. B. & Nagathihalli, N. S., Feb 1 2019, In : Oncotarget. 10, 10, p. 1056-1069 14 p.

    Research output: Contribution to journal › Article

    Open Access

    • Urolithin A, a novel natural compound to target PI3K/AKT/mTOR pathway in pancreatic cancer

    Totiger, T. M., Srinivasan, S., Jala, V. R., Lamichhane, P., Dosch, A. R., Gaidarski, A. A., Joshi, C., Rangappa, S., Castellanos, J., Vemula, P. K., Chen, X., Kwon, D., Kashikar, N., VanSaun, M., Merchant, N. B. & Nagathihalli, N. S., Feb 2019, In : Molecular cancer therapeutics. 18, 2, p. 301-311 11 p.

    Research output: Contribution to journal › Article

    • 7 Scopus citations

    Inverse correlation of STAT3 and MEK signaling mediates resistance to Ras pathway inhibition in pancreatic cancer

    Nagathihalli, N., Castellanos, J. A., Lamichhane, P., Messaggio, F., Shi, C., Dai, X., Rai, P., Chen, X., Vansaun, M. & Merchant, N., Nov 1 2018, In : Cancer Research. 78, 21, p. 6235-6246 12 p.

    Research output: Contribution to journal › Article

    • 10 Scopus citations